Catalent makes moves to advance its next-gen manufacturing
Catalent won access to IRO and launched a next-generation development platform.
Catalent
Private
Global contract development and manufacturing organization (CDMO) providing drug delivery technologies, development, manufacturing, biologics, gene therapy and consumer health services; a privately held subsidiary of Novo Holdings.
Company Info
Sector:CDMO / Contract Manufacturing
Headquarters:Tampa, Florida, United States
Founded:2007
Website:www.catalent.com/
Funding & Investor Relations
Notable Investors
- Novo Holdings